Toggle navigation
Browse
Home
People
Departments & Colleges
Research
Research Area Overlaps
Safety, Tolerability, Systemic Exposure, and Metabolism of CRS3123, a MethionyltRNA Synthetase Inhibitor Developed for Treatment of Clostridium difficile, in a Phase 1 Study
Article (Web of Science)
International Collaboration
Overview
Research
Additional Document Info
View All
Overview
cited authors
Nayak, Seema U.; Griffiss, J. McLeod; Blumer, Jeffrey; O'Riordan, Mary Ann; Gray, Wesley; McKenzie, Robin; Jurao, Robert A.; An, Amanda T.; Le, Melissa; Bell, Stacie J.; Ochsner, Urs A.; Jarvis, Thale C.; Janjic, Nebojsa; Zenilman, Jonathan M.
publication date
August 1, 2017
webpage
Web of Science
published in
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Journal
Research
category
PHARMACOLOGY & PHARMACY
Category
keywords
CRS3123
Clostridium difficile
Gram-positive bacteria
antimicrobial agents
glucuronidation
pharmacokinetics
Additional Document Info
volume
61
issue
8